Is Johnson & Johnson's effort coming to a waste? What illness was present to the patient? Johnson & Johnson's medical arm, Janssen, sees an unfortunate pause for its Novel Coronavirus (COVID-19) vaccine trials as "unexpected illness" was seen on patients, right on the company's phase three.